1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D375DC190908AD5F852580AB005DA580
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/strategies-developing-strong-field-based-medical-teams
18
19
2054.226.73.255
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Science Liaison

Strategies for Developing Strong Field-Based Medical Teams

ID: POP-278


Features:

21 Info Graphics

42 Data Graphics

300 Metrics

10 Narratives

20 Best Practices


Pages: 76


Published: 2017


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
As companies bring diverse sets of field-based medical liaisons into the field to work with physicians, payers and patients, it becomes imperative to clarify what roles each type of liaison might serve.


With the demand for scientific and medical data increasing, field-based medical teams must create strong strategies and utilize limited resources to meet the needs of thought leaders. This can be challenging as they face growing internal and external expectations regarding the types of activities and services they must provide.

Best Practices, LLC undertook this research to provide greater insights into the deployment of MSLs, Outcomes, nurse educators and their direct field-based supervisors. This study examines issues around field-based medical team staffing, activity timing, and training.


Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Chemical; Biopharmaceutical; Health Care; Laboratories; Clinical Research


Companies Profiled:
AbbVie; AstraZeneca; Bayer; EMD Serono; Genentech; Genzyme; Incyte; Kyowa Kirin; Medivation; Merck; Novartis; Pfizer; Pierre Fabre; Sanofi; Santen; Shire; Tocagen; ViiV Healthcare; ZS Pharma


Study Snapshot

Best Practices, LLC engaged 19 leaders with direct experience working in Medical Affairs. Participants represent 19 leading biopharmaceutical companies.

Key Findings

1. Time Allocation on MSL and HOL (Health Outcomes Liaison) Activities: There are gaps between expected and actual time allocation on several MSL and HOL activities. For example MSLs spend more time on the three activities than expected:

      · Administrative and reporting: 12.5% more actual time allocation than expected
      · Clinical trial support: 33% more actual time allocation than expected
      · Site identification for clinical trials: 38.5% more actual time allocation than expected

2. Medical Science Liaisons Dominate Field-Based Medical Team Staff: Ninety-five percent of the participants have MSLs in their Field-Based Medical Teams, whereas only 29% of the participants also have Health Outcomes Liaisons. On average: MSL teams are composed of 86 employees, while HOL teams are composed of 33 employees.

Table of Contents

Executive Summarypgs. 3-9 
Research Overviewpg. 3
Participating Companies  pg. 4
Segmentation  pg. 5
High-Level Recommendations pg. 6
Key Findings  pgs. 7-9
Actual vs. Expected Time Allocationpgs. 10-13
Showing the Value to Key Stakeholders  pgs. 14-21
Key Performance Indicators  pgs. 22-31
Visit Frequency  pgs. 32-35
Field-Based Medical Team Salaries pgs. 36-41
Span of Control and Headcountpgs. 42-47
Reasons of Change in FBMT Headcount   pgs. 48-58
Planning Field-Based Medical Team Training  pgs. 59-62
Duration of Trainingpgs. 63-69
Participant Demographicspgs. 70-74
About Best Practices, LLC pgs. 75-76


List of Charts & Exhibits

Time Allocation: MSLs
  • Time Allocation: HOLs
  • Actual Time Spent for Top 10 Valuable Activities for MSLs
  • Value: MSLs
  • Value: MSLs - US Only vs. Global
  • Value: MSLs - Large Vs. Small Companies
  • Actual Time Spent vs. Top 10 Valuable Activities for HOLs
  • Value: HOLs
  • Usage and Effectiveness of Metrics
  • Qualitative Metrics
  • Implementing Qualitative Metrics
  • Quantitative Metrics
  • Activities Used to Measure Performance
  • Quantitative Metrics: US Only vs. Global
  • Quantitative Metrics: Large vs. Small Companies
  • Implementing Quantitative Metrics
  • Building and Maintaining Thought Leader Relationship: MSLs, HOLs
  • Salaries: MSLs, MSL Managers, MSL Directors, HOLs
  • Field-Based Medical Team Member Types
  • Number of FTEs: MSLs, HOLs
  • FTE Involvement: MSLs
  • Span of Control: MSLs
  • Reasons Behind Change in Field-Based Medical Team Numbers
  • Increasing the Number of Field-Based Medical Team: MSLs (3)
  • Increasing the Number of Field-Based Medical Teams: HOLs
  • Decreasing the Number of Field-Based Medical Teams: MSLs (3)
  • Decreasing the Number of Field-Based Medical Teams: HOLs
  • Training Standardization vs. Customization
  • Frequency of Training: MSLs
  • Training Formats
  • Training Frequency and Duration (2)
  • Training Duration: MSLs, HOLs
  • Training Duration: Large vs. Small Companies
  • Geographic Span
  • Participant's Job Title
  • Reporting Level (2)